Studies have demonstrated that suppressing AR expression with RNA interference (RNAi) technology is an effective way to inhibit the growth of prostate cancer cells, indicating that this method may have the potential to overcome hurdles associated with AIPC treatment [5]. The gene discussed is AR; the disease is prostate carcinoma.